Monthly Prescribing Reference

Spiriva Respimat Gains Indication and New Dosage Strength

Boehringer Ingelheim announced that Spiriva Respimat (tiotropium bromide) is now available for the long-term maintenance treatment of asthma in patients ages ≥12 years. Boehringer Ingelheim announced ...
Monthly Prescribing Reference

Spiriva Respimat Approved for COPD Maintenance

Tiotropium as Asthma Add-On Treatment Shows Promise Boehringer Ingelheim announced that the Food and Drug Administration (FDA) has approved Spiriva Respimat (tiotropium bromide) inhalation spray for ...
Healio

Spiriva Respimat reduces risk for asthma worsening, regardless of underlying allergic inflammation

Please provide your email address to receive an email when new articles are posted on . MONTREAL — Spiriva Respimat, as an add-on to inhaled corticosteroids or long-acting beta2 agonists, reduced the ...
PharmaTimes

BI boosted by strong Spiriva Respimat data

Boehringer vigorously defended Respimat at the time, pointing out that the findings of the pooled data were flawed. Commenting on TIOSPIR, Richard Russell of the Wexham Park Hospital in the UK, said ...
FiercePharma

Asthma’s a real bear in Boehringer Ingelheim’s new TV campaign for Spiriva Respimat

Want to know what asthma feels like? Try a crushing bear hug. That’s what patients told Boehringer Ingelheim, informing its latest campaign for Spiriva Respimat as a treatment for asthma. In new TV ...
FiercePharma

SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray Now Available in the United States

SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...
Healthline

Spiriva Side Effects and Tips for Managing Them

Spiriva (tiotropium), available as Respimat and Handihaler, is prescribed to treat COPD and asthma but should not be used as a rescue inhaler for sudden breathing issues. Common side effects of ...
Healthline

How to Use Spiriva for COPD and Asthma

Spiriva (tiotropium bromide) is an anticholinergic medication that relaxes airway muscles to ease breathing in chronic obstructive pulmonary disease (COPD) and asthma. It’s meant for long-term daily ...
PharmaTimes

FDA approves BI’s Spiriva Respimat for COPD

Boehringer Ingelheim is celebrating after the US Food and Drug Administration approved the mist version of its chronic obstructive pulmonary disease blockbuster Spiriva. Boehringer Ingelheim is ...
Medical News Today

Spiriva side effects: Mild to serious and management tips

Spiriva (tiotropium bromide) is an inhaler used for chronic obstructive pulmonary disease (COPD) in adults and asthma in adults and certain children. Common side effects include sore throat, sinus ...
Healio

FDA approves Spiriva Respimat for asthma in adults, adolescents

Please provide your email address to receive an email when new articles are posted on . The FDA approved Spiriva Respimat for the long-term, once-daily treatment of asthma in patients aged 12 years ...
Medscape

FDA OKs Mist Spray Form of Tiotropium (Spiriva Respimat)

The US Food and Drug Administration (FDA) yesterday approved an inhalation spray version of tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim) for maintenance treatment of chronic obstructive ...